Zolpidem tartrate
- Product NDC
- 63629-4597
- 11-digit product format
- 636294597
- Labeler code
- 63629
- Product ID
- 63629-4597_56db3e80-5b7e-4611-92c7-88ed80f4e657
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zolpidem tartrate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA090107
- Marketing category
- ANDA
- Marketing start
- 2011-10-31
- Substance
- ZOLPIDEM TARTRATE
- Active strength
- 12.5 mg/1
- Pharmacologic classes
- Central Nervous System Depression [PE], GABA A Receptor Positive Modulators [MoA], gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Zolpidem tartrate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ZOLPIDEM TARTRATE | 12.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WY6W63843K |
| Rxcui | 854880 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 63629-4597-1 | 2024-09-10 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-2 | 2024-09-10 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-3 | 2024-09-10 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-4 | 2024-09-10 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-5 | 2024-09-10 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-6 | 2024-09-10 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-1 | 2024-01-30 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-2 | 2024-01-30 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-3 | 2024-01-30 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-4 | 2024-01-30 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-5 | 2024-01-30 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-6 | 2024-01-30 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-1 | 2022-02-16 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-2 | 2022-02-16 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
| 63629-4597-2 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d445-cd31-e053-dbdaa90ab51a | These highlights do not include all the information needed to use ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE EXTENDED-RELEASE TABLETS. ZOLPIDEM tartrate extended-release tablets, for oral use C-IV Initial U.S. Approval: 1992 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63629-4597-1 | Zolpidem tartrate | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1004 |
| 63629-4597-2 | Zolpidem tartrate | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 1004 |
| 63629-4597-3 | Zolpidem tartrate | 28 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 28 | | 1004 |
| 63629-4597-4 | Zolpidem tartrate | 8 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 8 | | 1004 |
| 63629-4597-5 | Zolpidem tartrate | 18 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 18 | | 1004 |
| 63629-4597-6 | Zolpidem tartrate | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 1004 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ZOLPIDEM TARTRATE | ACTIVE INGREDIENT | WY6W63843K | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| ZOLPIDEM | ACTIVE MOIETY | 7K383OQI23 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63629-4597 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1004 | Current NDC, Legacy NDC, 6 package rows | 20240912_ce301d8b-0a8c-4404-8697-57222ae17a44.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-4597-1 | 63629459701 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4597-1) | 2012-08-29 | 0000-00-00 | No | No | Current |
| 63629-4597-2 | 63629459702 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4597-2) | 2015-11-16 | 0000-00-00 | No | No | Current |
| 63629-4597-3 | 63629459703 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4597-3) | 2024-09-05 | 0000-00-00 | No | No | Current |
| 63629-4597-4 | 63629459704 | 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4597-4) | 2024-09-05 | 0000-00-00 | No | No | Current |
| 63629-4597-5 | 63629459705 | 18 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4597-5) | 2024-09-05 | 0000-00-00 | No | No | Current |
| 63629-4597-6 | 63629459706 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4597-6) | 2024-09-05 | 0000-00-00 | No | No | Current |